BridgeBio to Participate in September Investor Conferences
BridgeBio Pharma (Nasdaq: BBIO), a biopharmaceutical company focused on genetic diseases, has announced its participation in three major healthcare investor conferences in September 2025. The management team will host fireside chats at the Wells Fargo Healthcare Conference in Boston (September 3), the Cantor Global Healthcare Conference in New York (September 4), and the Morgan Stanley Global Healthcare Conference in New York (September 8).
Investors can access live webcasts of the presentations through BridgeBio's investor relations website, with replays available for 90 days following each event.
BridgeBio Pharma (Nasdaq: BBIO), azienda biofarmaceutica specializzata nelle malattie genetiche, ha comunicato la propria partecipazione a tre importanti conferenze per investitori del settore sanitario a settembre 2025. Il team di gestione terrà conversation informali (fireside chats) al Wells Fargo Healthcare Conference di Boston (3 settembre), al Cantor Global Healthcare Conference di New York (4 settembre) e al Morgan Stanley Global Healthcare Conference di New York (8 settembre).
Gli investitori potranno seguire le presentazioni in diretta tramite il sito web per gli investitori di BridgeBio; le registrazioni saranno disponibili in replay per 90 giorni dopo ogni evento.
BridgeBio Pharma (Nasdaq: BBIO), compañía biofarmacéutica centrada en enfermedades genéticas, ha anunciado su participación en tres importantes conferencias para inversores del sector salud en septiembre de 2025. El equipo directivo ofrecerá charlas informales (fireside chats) en el Wells Fargo Healthcare Conference en Boston (3 de septiembre), en el Cantor Global Healthcare Conference en Nueva York (4 de septiembre) y en el Morgan Stanley Global Healthcare Conference en Nueva York (8 de septiembre).
Los inversores podrán acceder a las retransmisiones en directo a través del sitio web de relaciones con inversores de BridgeBio; las repeticiones estarán disponibles durante 90 días tras cada evento.
BridgeBio Pharma (Nasdaq: BBIO), 유전 질환에 주력하는 바이오제약사인 이 회사는 2025년 9월 주요 헬스케어 투자자 컨퍼런스 세 곳에 참가한다고 발표했습니다. 경영진이 보스턴의 Wells Fargo Healthcare Conference(9월 3일), 뉴욕의 Cantor Global Healthcare Conference(9월 4일), 뉴욕의 Morgan Stanley Global Healthcare Conference(9월 8일)에서 파이어사이드 채팅(fireside chats)을 진행합니다.
투자자들은 BridgeBio의 투자자 관계 웹사이트를 통해 발표를 생중계로 시청할 수 있으며, 각 행사 후 90일간 재시청(replay)이 가능합니다.
BridgeBio Pharma (Nasdaq: BBIO), société biopharmaceutique spécialisée dans les maladies génétiques, a annoncé sa participation à trois grandes conférences pour investisseurs du secteur de la santé en septembre 2025. L'équipe de direction animera des « fireside chats » lors du Wells Fargo Healthcare Conference à Boston (3 septembre), du Cantor Global Healthcare Conference à New York (4 septembre) et du Morgan Stanley Global Healthcare Conference à New York (8 septembre).
Les investisseurs pourront suivre les présentations en diffusion en direct via le site relations investisseurs de BridgeBio ; les rediffusions seront disponibles pendant 90 jours après chaque événement.
BridgeBio Pharma (Nasdaq: BBIO), ein biopharmazeutisches Unternehmen mit Schwerpunkt auf genetischen Erkrankungen, hat seine Teilnahme an drei bedeutenden Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Management wird Fireside Chats beim Wells Fargo Healthcare Conference in Boston (3. September), beim Cantor Global Healthcare Conference in New York (4. September) und beim Morgan Stanley Global Healthcare Conference in New York (8. September) abhalten.
Investoren können die Präsentationen per Live-Webcast über die Investor-Relations-Website von BridgeBio verfolgen; Aufzeichnungen stehen jeweils für 90 Tage nach der Veranstaltung zur Verfügung.
- None.
- None.
PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host fireside chats at the following healthcare investor conferences:
- Wells Fargo Healthcare Conference, Boston, MA: Fireside chat on Wednesday, September 3 at 9:30 am ET
- Cantor Global Healthcare Conference – New York, NY: Fireside chat on Thursday, September 4 at 2:10 pm ET
- Morgan Stanley Global Healthcare Conference – New York, NY: Fireside chat on Monday, September 8 at 3:20 pm ET
To access the live webcast of BridgeBio’s presentations, please visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter, Facebook, Instagram and YouTube.
BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com
(650)-789-8220
BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com
FAQ
When and where will BridgeBio (BBIO) present at the Wells Fargo Healthcare Conference in September 2025?
How can investors access BridgeBio's (BBIO) September 2025 conference presentations?
Which investor conferences will BridgeBio (BBIO) attend in September 2025?
What time is BridgeBio's (BBIO) presentation at the Morgan Stanley Global Healthcare Conference?
